Results 71 to 80 of about 633 (125)
Some of the next articles are maybe not open access.

Aurothioglucose overdosage in five patients with rheumatoid arthritis

Clinical Rheumatology, 1987
Five patients with active seronegative, rheumatoid arthritis, HLA-DR3 negative, received inadvertently 250 to 500 mg of aurothioglucose instead of their usual weekly dose, during standard remission-inducing chrysotherapy. Subsequently a rapid and sustained clinical remission appeared in all five patients.
I Rubinstein, M Pras, Langevitz P
exaly   +3 more sources

Aurothioglucose

2008
Jennifer Minigh
exaly   +2 more sources

Persistent dynamic phase of aurothioglucose obesity

American Journal of Physiology-Legacy Content, 1963
Continuous long-term observations on food intake, body weight, and the development of obesity were made on the survivors of an ld50 dose of aurothioglucose (ATG). ATG-obese mice consumed significantly greater amounts of food compared to ATG-nonobese and control animals from the 2nd to the 13th months of observation. The daily food consumption of obese
G, Friedman, J D, Waye, H D, Janowitz
openaire   +2 more sources

Relationship of food and water intake in aurothioglucose obesity

American Journal of Physiology-Legacy Content, 1962
After ld50 doses of aurothioglucose (ATG), extensive damage to hypothalamic structures other than those strictly involved in food intake has been demonstrated. The injury to areas previously shown to be concerned with the regulation of water intake prompted an investigation of the daily patterns of food and water intake in mice from the 2nd day after ...
G, FRIEDMAN, J D, WAYE, H D, JANOWITZ
openaire   +2 more sources

Stimulation of human neutrophil migration by aurothioglucose and thioglucose

Agents and Actions, 1993
Migration of human neutrophils was enhanced by aurothioglucose in a concentration-dependent manner. Migration was especially pronounced when the drug was present in the lower compartment of the Boyden chamber, suggesting that the enhancement of migration was chemotactic rather than chemokinetic.
J G, Elferink, B M, de Koster
openaire   +2 more sources

Aurothioglucose in rheumatoid arthritis

Medical Journal of Australia, 1984
Forty-three patients in whom treatment with sodium aurothiomalate was discontinued because of adverse reactions that either were relatively severe or recurred on rechallenge received treatment with aurothioglucose in oily base. Thirty-six of them had rheumatoid arthritis, four had psoriatic arthritis and three had juvenile chronic arthritis ...
E E, McGirr   +4 more
openaire   +2 more sources

Development of obesity and neurochemical backing in aurothioglucose-treated mice

Autonomic Neuroscience, 2001
To clarify the neurochemical backing of aurothioglucose (ATG)-induced obesity in mice, we investigated lesion sites, hypothalamic neurotransmitters and c-Fos-like immunoreactivity (Fos-IR). At day 2 after ATG, tissue loss or cells death was observed in several parts of the ventral area of the ventromedial hypothalamic nucleus (VMH), and the dorsal area
E, Kishi   +4 more
openaire   +2 more sources

Aurothioglucose

Reactions Weekly, 1999
openaire   +2 more sources

Aurothioglucose

Reactions Weekly, 1993
openaire   +2 more sources

Home - About - Disclaimer - Privacy